Skip to content
ZL
Company

Updated:

Zyla Life Sciences

Zyla Life Sciences is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001586105, and its reported industry is...

Overview

Zyla Life Sciences is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001586105, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2019-03-29, it reported annual revenue of USD 30,353,000; total assets of USD 61,933,000 for the fiscal period ended 2018-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
Zyla Life Sciences
Former names in filing history
Egalet Corp (2013-09-17 to 2019-05-20)
Classification
Company
Industry (SIC)
2834 — Pharmaceutical Preparations
Headquarters
Wayne, PA, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0001586105

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueTotal assetsCash and equivalentsOperating cash flow
FY2018USD$30.4M$61.9M$35.3M-$54.8M
FY2017USD$26.1M$119.9M$31.1M-$65.2M
FY2016USD$17.0M$114.9M$44.4M—
FY2015USD$22.8M$172.4M$46.7M—

Recent SEC filings

FormFiledPeriodFiling
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K
10-Q10-Q
10-K/A10-K/A
DEF 14ADEF 14A
8-KFORM 8-K
8-KFORM 8-K
10-K10-K
SC 13D—SC 13D
8-KFORM 8-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research Zyla Life Sciences in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles